# Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects

> **NCT01001013** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LC15-0444, Pioglitazone

## Key facts

- **NCT ID:** NCT01001013
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2010-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001013, "Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01001013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*